1. Home
  2. COCP vs ABTS Comparison

COCP vs ABTS Comparison

Compare COCP & ABTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COCP
  • ABTS
  • Stock Information
  • Founded
  • COCP N/A
  • ABTS 2010
  • Country
  • COCP United States
  • ABTS Hong Kong
  • Employees
  • COCP N/A
  • ABTS N/A
  • Industry
  • COCP Biotechnology: Pharmaceutical Preparations
  • ABTS Computer Software: Programming Data Processing
  • Sector
  • COCP Health Care
  • ABTS Technology
  • Exchange
  • COCP Nasdaq
  • ABTS Nasdaq
  • Market Cap
  • COCP 18.3M
  • ABTS 16.0M
  • IPO Year
  • COCP N/A
  • ABTS N/A
  • Fundamental
  • Price
  • COCP $1.99
  • ABTS $0.54
  • Analyst Decision
  • COCP Strong Buy
  • ABTS
  • Analyst Count
  • COCP 1
  • ABTS 0
  • Target Price
  • COCP $7.00
  • ABTS N/A
  • AVG Volume (30 Days)
  • COCP 14.9K
  • ABTS 90.7K
  • Earning Date
  • COCP 11-13-2024
  • ABTS 12-31-2024
  • Dividend Yield
  • COCP N/A
  • ABTS N/A
  • EPS Growth
  • COCP N/A
  • ABTS N/A
  • EPS
  • COCP N/A
  • ABTS N/A
  • Revenue
  • COCP N/A
  • ABTS $5,343,888.00
  • Revenue This Year
  • COCP N/A
  • ABTS N/A
  • Revenue Next Year
  • COCP N/A
  • ABTS N/A
  • P/E Ratio
  • COCP N/A
  • ABTS N/A
  • Revenue Growth
  • COCP N/A
  • ABTS 3970.67
  • 52 Week Low
  • COCP $1.33
  • ABTS $0.38
  • 52 Week High
  • COCP $3.10
  • ABTS $1.60
  • Technical
  • Relative Strength Index (RSI)
  • COCP 51.27
  • ABTS 46.97
  • Support Level
  • COCP $1.83
  • ABTS $0.41
  • Resistance Level
  • COCP $2.07
  • ABTS $0.53
  • Average True Range (ATR)
  • COCP 0.11
  • ABTS 0.07
  • MACD
  • COCP -0.01
  • ABTS -0.02
  • Stochastic Oscillator
  • COCP 44.74
  • ABTS 40.97

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

About ABTS Abits Group Inc

Abits Group Inc is a digital data center operator with bitcoin self-mining operations.

Share on Social Networks: